Effect of rituximab in MCNS: a role for IL-13 suppression?
Authors:
- Ji Eun KimJKJi Eun Kim
- Se Jin ParkSPSe Jin Park
- Tae-Sun HaTHTae-Sun Ha
- Jae Il ShinJae Il Shin
- 30 July 2013
- journal article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 9 (9) , 551
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Rituximab therapy in nephrotic syndrome: implications for patients' managementNature Reviews Nephrology, 2013
- New Drug Targets in Atopic Dermatitis2012
- Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in RatsJournal of the American Society of Nephrology, 2007
- Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndromePediatric Nephrology, 2004
- Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse.1999
- Th1 and Th2 Cytokine mRNA Profiles in Childhood Nephrotic SyndromeJournal of the American Society of Nephrology, 1999